<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="treatment used for malaria, which widely involves the use of" exact="chloroquine" post="and its derivatives (in particular, hydroxychloroquine). These drugs are"/>
 <result pre="[13,14]. More recently, some authors have reported the usefulness of" exact="hydroxychloroquine" post="at a dosage of 400 mg per day for"/>
 <result pre="contributes to increasing their efficacy in vivo [16]. Of note," exact="chloroquine" post="is commonly used in several countries in the treatment"/>
 <result pre="MERS-CoV [18]. Surprisingly, even some medications used in cases of" exact="chloroquine" post="resistance (e.g., doxycycline, azithromycin) have demonstrated antiviral action against"/>
 <result pre="non-African countries. For instance, the effect of the administration of" exact="chloroquine" post="derivatives in areas where malaria is endemic seems to"/>
 <result pre="clinical trials are currently underway to verify the efficacy of" exact="chloroquine" post="and its derivates for COVID-19 (e.g., NCT04261517, 2/14/20; ChiCTR2000029826,"/>
 <result pre="derivates for COVID-19 (e.g., NCT04261517, 2/14/20; ChiCTR2000029826, 2/2/20) [20]. Interestingly," exact="hydroxychloroquine" post="is a less toxic derivate of chloroquine that has"/>
 <result pre="2/2/20) [20]. Interestingly, hydroxychloroquine is a less toxic derivate of" exact="chloroquine" post="that has demonstrated potential against Beta-CoVs [21]. In particular,"/>
 <result pre="economic and social outcomes. Even the mere prophylactic administration of" exact="chloroquine" post="or its derivatives to â€˜exposedâ€™ health workers would help"/>
 <result pre="role of the renin-angiotensin systemFront. Cell. Infect. Microbiol.2016510310.3389/fcimb.2015.0010326779452 13.SavarinoA.BoelaertJ.R.CassoneA.MajoriG.CaudaR.Effects of" exact="chloroquine" post="on viral infections: An old drug against todayâ€™s diseasesLancet"/>
 <result pre="therapiesDrugs2017771935196610.1007/s40265-017-0830-129143192 16.CortegianiA.IngogliaG.IppolitoM.GiarratanoA.EinavS.A systematic review on the efficacy and safety of" exact="chloroquine" post="for the treatment of COVID-19J. Crit. Care202010.1016/j.jcrc.2020.03.00532173110 17.OcanM.AkenaD.NsobyaS.KamyaM.R.SenonoR.KinengyereA.A.ObukuE.A.Persistence of"/>
 <result pre="chloroquine for the treatment of COVID-19J. Crit. Care202010.1016/j.jcrc.2020.03.00532173110 17.OcanM.AkenaD.NsobyaS.KamyaM.R.SenonoR.KinengyereA.A.ObukuE.A.Persistence of" exact="chloroquine" post="resistance alleles in malaria endemic countries: A systematic review"/>
 <result pre="of burden and risk factorsMalar. J.20191810.1186/s12936-019-2716-z30871535 18.Al-BariM.A.A.Targeting endosomal acidification by" exact="chloroquine" post="analogs as a promising strategy for the treatment of"/>
</results>
